It also functions as a tumor suppressor by directly binding to receptor tyrosine kinases, including VEGFR2, EGFR, PDGFR, and MET, and triggering catabolic and antiangiogenic programs in tumor cells (24). This evidence concerns the gene NTRK1 and neoplasm.